Literature DB >> 19174739

Afferent pathways involved in cardiovascular adjustments induced by hypertonic saline resuscitation in rats submitted to hemorrhagic shock.

Eloísa Ferreira de Almeida Costa1, Gustavo Rodrigues Pedrino, Oswaldo Ubríaco Lopes, Sergio Luiz Cravo.   

Abstract

The peripheral hyperosmolarity elicited by intravenous infusion of hypertonic saline (HS) can be beneficial in treating hemorrhagic shock. However, the neural mechanisms involved in this resuscitation remain unknown. The present study sought to determine the effects of selective baroreceptor denervation on arterial blood pressure response during HS resuscitation in rats submitted to hemorrhagic shock. Male Wistar rats (280-320 g) were anesthetized with thiopental sodium (40 mg/kg, i.v.), and the femoral artery and jugular vein were cannulated for MAP and heart rate recording and HS infusion (3 mol/L NaCl; 0.18 mL/100 g body weight, >2 min). Hemorrhagic shock was obtained by withdrawing blood over 30 min until a MAP of 60 mmHg was obtained. This level of MAP was maintained for a further 30 min through subsequent blood withdrawal or reinfusion. Next, animals were divided into selective aortic and/or carotid denervation or sham groups before infusing HS. Results showed that in the sham group (n = 12), HS infusion increased MAP to levels close to baseline (from 65 +/- 3 to 112 +/- 5 mmHg, 10 min after HS). In the aortic denervated group (n = 10), HS infusion also increased MAP (from 54 +/- 3 to 112 +/- 5 mmHg, 10 min after HS). In contrast, in the carotid denervation group (n = 8), the increase in MAP induced by HS infusion was abolished (from 53 +/- 3 to 73 +/- 12 mmHg, 10 min after HS). These results indicate that in hemorrhaged rats, HS infusion produces a pressor effect that is likely to be mediated through carotid rather than aortic baroreceptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174739     DOI: 10.1097/SHK.0b013e31819c3841

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  Use and effect of vasopressors after pediatric traumatic brain injury.

Authors:  Jane L Di Gennaro; Christopher D Mack; Amin Malakouti; Jerry J Zimmerman; William Armstead; Monica S Vavilala
Journal:  Dev Neurosci       Date:  2010-12-02       Impact factor: 2.984

2.  Intracarotid hypertonic sodium chloride differentially modulates sympathetic nerve activity to the heart and kidney.

Authors:  Robert Frithiof; Tao Xing; Michael J McKinley; Clive N May; Rohit Ramchandra
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

3.  Medullary Noradrenergic Neurons Mediate Hemodynamic Responses to Osmotic and Volume Challenges.

Authors:  Stefanne Madalena Marques; Lara Marques Naves; Talita de Melo E Silva; Keilah Valéria Naves Cavalcante; Juliana Milan Alves; Marcos Luiz Ferreira-Neto; Carlos Henrique de Castro; Andre Henrique Freiria-Oliveira; James Oluwagbamigbe Fajemiroye; Rodrigo Mello Gomes; Eduardo Colombari; Carlos Henrique Xavier; Gustavo Rodrigues Pedrino
Journal:  Front Physiol       Date:  2021-04-23       Impact factor: 4.566

4.  Involvement of median preoptic nucleus and medullary noradrenergic neurons in cardiovascular and sympathetic responses of hemorrhagic rats.

Authors:  Lara Marques Naves; Stefanne Madalena Marques; Aline Andrade Mourão; James Oluwagbamigbe Fajemiroye; Carlos Henrique Xavier; Carlos Henrique de Castro; Ana Cristina Silva Rebelo; Daniel Alves Rosa; Rodrigo Mello Gomes; Eduardo Colombari; Gustavo Rodrigues Pedrino
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

5.  Median preoptic nucleus mediates the cardiovascular recovery induced by hypertonic saline in hemorrhagic shock.

Authors:  Nathalia Oda Amaral; Lara Marques Naves; Marcos Luiz Ferreira-Neto; André Henrique Freiria-Oliveira; Eduardo Colombari; Daniel Alves Rosa; Angela Adamski da Silva Reis; Danielle Ianzer; Carlos Henrique Xavier; Gustavo Rodrigues Pedrino
Journal:  ScientificWorldJournal       Date:  2014-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.